Components of the LRP4/MuSK/Dok-7 complex are the targets of mutations responsible for subsets of congenital myasthenic syndromes (CMS), which are characterized by fatigable muscle weakness (11). The gene discussed is LRP4; the disease is congenital myasthenic syndrome.